MRK

#42
Merck & Company, Inc. Common Stock
118.7 4 USD
-0.74%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
118.22
119.67
Faixa anual
75.40
125.14
Mudança diária
-0.74%
Mudança mensal
+7.97%
Mudança em 6 meses
+13.55%
Mudança anual
+54.33%
Fechamento anterior
119.6 2
Open
119.6 5
Mínimo
118.2 2
High
119.6 7
Volume
3 690
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 293.27 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Fabricantes de medicamentos - gerais
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
33.88
Índice preço/fluxo de caixa
4.57
Dividendos por ação
0.85
Rendimento de dividendos, %
4.78

Merck & Company, Inc. Common Stock

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Notícias